[内镜下粘膜剖析作为性结肠炎患者直肠病变的治疗选择]
Ianina Belén Capaldi1, Florencia Giraudo1, María Laura Garbi1
1Servicio de Gastroenterología, HIGA San Martín de La Plata. Provincia de Buenos Aires, Argentina. Servicio de Gastroenterología HIGA San Martín La PlataBuenos Aires Argentina.
Acta gastroenterologica Latinoamericana
|December 4, 2025
概括
性结肠炎监测检测到一个80岁的病人直肠病变. 内镜下粘膜切割成功地去除了病变,证明了其在管理高风险结直肠疾病方面的有效性.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 内镜检查是指内镜检查.
背景情况:
- 性结肠炎 (UC) 是一种具有持续粘膜炎症的慢性炎症性肠病 (IBD).
- UC增加了结直肠癌 (CRC) 的风险,需要定期监测结直肠镜.
- 在UC患者中早期发现和治疗癌前病变至关重要.
研究的目的:
- 报告一个患有广泛性结肠炎的老年患者结肠直肠癌监测病例.
- 在这种情况下,要突出成功地应用内镜下膜解剖 (ESD) 来治疗直肠病变.
主要方法:
- 在一个80岁的病人身上进行了监视结肠镜检查,该患者有35年的广泛性性结肠炎病史.
- 在中直肠中发现了一个30毫米的非颗粒状,伪压抑的横向生长病变.
- 用了内镜下膜剖析 (ESD) 来完全切除直肠病变.
主要成果:
- 内镜下粘膜剖析 (ESD) 程序没有任何并发症完成.
- 该技术允许对直肠病变进行完全和块状切除.
- 这一案例证明了ESD的实用性,即使在潜在的亚粘膜纤维化病例中也是如此.
结论:
- 内镜下粘膜切割 (ESD) 是一种有价值的先进内镜技术,用于切除性结肠炎患者的癌前病变.
- ESD为结直肠病变提供了安全有效的治疗选择,包括具有具有挑战性特征的结直肠病变,如亚粘膜纤维化.
- 这一案例强调了持续监测和先进的内镜干预在治疗性结肠炎和预防结肠直肠癌方面的重要性.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
428
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
428
Drugs for Treatment of Ulcerative Colitis in IBD
431
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
431
Drugs for Treatment of Diarrhea-Predominant IBS
599
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
599
Peptic Ulcer Disease IV: Management
406
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
406
Inflammatory Bowel Disease IV: Pharmacological Management
450
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
450
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
617
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
617


